Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 25;10(35):40342-40353.
doi: 10.1021/acsomega.5c05628. eCollection 2025 Sep 9.

Structural Characterizations and In Vitro Bioactivities of a d‑Fructose-Rich Polysaccharide from Gymnopetalum cochinchinense as a Potential Candidate for Alleviating Alzheimer's Disease

Affiliations

Structural Characterizations and In Vitro Bioactivities of a d‑Fructose-Rich Polysaccharide from Gymnopetalum cochinchinense as a Potential Candidate for Alleviating Alzheimer's Disease

Do Thi Thuy Van et al. ACS Omega. .

Abstract

The presented investigation attempts to unveil the structural characteristics, bioactivities, and potential application of Gymnopetalum cochinchinense-derived d-fructose-rich heteropolysaccharide (denoted as PS-HB5) for the treatment of Alzheimer's disease (AD). Structural analyses of the PS-HB5 evaluated by FT-IR, GC-MS, and NMR techniques reveal a novel repeating unit composed of d-glucose and d-fructose linked through (1 → 6)-glucosyl, (2 → 6)-fructosyl, and (2 → 4)-fructosyl bonds, and possesses a molecular weight of 1.217 × 105 Da. The PS-HB5 exhibits strong antioxidant activity, as evidenced by its DPPH and ABTS radical scavenging rates of 84.12% and 74.14%, associated with the IC50 values of 0.80 and 3.06 mg.mL-1, respectively. In addition, the PS-HB5 shows an inhibition rate of 78.37% (IC50 = 221.96 μg.mL-1) toward nitric oxide (NO) production in LPS-stimulated macrophages. Cytotoxicity assays indicate selective inhibition of the PS-HB5 against HepG2 and KB cancer cell lines (IC50 = 449.95 and 408.34 μg/mL), with minimal impact on MCF-7 and SK-LU-1. Interestingly, PS-HB5 demonstrates an outstanding AChE inhibitory effect, achieving 41.01% inhibition at 500 μg.mL-1, placing it among the most active AChE-inhibitory polysaccharides. These findings unveil the PS-HB5 potential as a candidate for the treatment of Alzheimer's Disease.

PubMed Disclaimer

Figures

1
1. Procedure for the Isolation of PS-HB5 from G. cochinchinense
1
1
GPHPLC chromatogram of PS-HB5 isolated from G. cochinchinense.
2
2
FT-IR spectrum of PS-HB5 isolated from G. cochinchinense.
3
3
1D-NMR spectra of PS-HB5. (A) 1H NMR; (B) 13C NMR.
4
4
HSQC spectrum of PS-HB5. (A) Overall; (B) expansion.
5
5
Enlarged regions of the HMBC spectrum of PS-HB5. (A) δ H 3.4–4.3 ppm/δ C 55–105 ppm; (B) δ H 3.4 ppm–4.3 ppm/δ C 58–83 ppm.
6
6
1H–1H COSY spectrum of PS-HB5.
7
7
1H–1H NOESY spectrum of PS-HB5.
8
8
Structure of the repeating units of PS-HB5 isolated from G. cochinchinense.
9
9
Scavenging effects of PS-HW1 on DPPH radical and ABTS+• radical.

References

    1. Tang J., Yousaf M., Wu Y.-P., Li Q.-q., Xu Y.-Q., Liu D.-M.. Mechanisms and structure-activity relationships of polysaccharides in the intervention of Alzheimer’s disease: A review. Int. J. Biol. Macromol. 2024;254:127553. doi: 10.1016/j.ijbiomac.2023.127553. - DOI - PubMed
    1. Selkoe D. J.. Treatments for Alzheimer’s disease emerge. Science. 2021;373(6555):624–626. doi: 10.1126/science.abi6401. - DOI - PubMed
    1. Ratan Y., Rajput A., Maleysm S., Pareek A., Jain V., Pareek A., Kaur R., Singh G.. An Insight into Cellular and Molecular Mechanisms Underlying the Pathogenesis of Neurodegeneration in Alzheimer’s Disease. Biomedicines. 2023;11:1398. doi: 10.3390/biomedicines11051398. - DOI - PMC - PubMed
    1. Murakami S., Lacayo P.. Biological and disease hallmarks of Alzheimer’s disease defined by Alzheimer’s disease genes. Front. Aging Neurosci. 2022;14:996030. doi: 10.3389/fnagi.2022.996030. - DOI - PMC - PubMed
    1. Cai Y., Li Y., Wang Y., Xu Y., Chen T., Xue R., Liu Y., Chen W., Yang X., Liu Z., Bao X., Huang Z.. Triple-mode sensing platform for acetylcholinesterase activity monitoring and anti-Alzheimer’s drug screening based on a highly stable Cu (I) compound. Biosens. Bioelectron. 2025;271:117078. doi: 10.1016/j.bios.2024.117078. - DOI - PubMed

LinkOut - more resources